RxDoctor Payments Data

Reham Ghali, PA

Physician Assistant · Raleigh, NCNPI 1639618226

Payments from drug & device makers

$17,132in general payments, 2019–2025

Across 502 payments — averaging $34.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$7K
  • AbbVie$3K
  • UCB, Inc.$664
  • Eisai Inc.$587
  • AstraZeneca$536
  • Lundbeck LLC$518
  • plus $5K from 53 others

What the payments were for

  • Consulting fees$4393%
  • Speaking & faculty fees$5,39231%
  • Travel & lodging$8955%
  • Food & beverage$10,20660%
  • Education$2001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axsome Therapeutics, Inc.23$7,029
AbbVie142$2,878
UCB, Inc.31$664
Eisai Inc.26$587
AstraZeneca(2 entities)18$536
Lundbeck LLC22$518
Amgen26$510
Argenx US, Inc.5$381
Impel Pharmaceuticals Inc.22$362
Pfizer18$340
Novartis14$264
Teva Pharmaceuticals USA, Inc.16$231
Johnson & Johnson13$223
E.r. Squibb & Sons, L.L.C.2$208
Biogen11$194
Biohaven Pharmaceutical Holding Company Ltd.11$167
Averitas Pharma Inc.1$123
SK Life Science, Inc.4$111
Lilly USA, LLC7$110
Otsuka America Pharmaceutical, Inc.6$108
Sanofi5$97
TG Therapeutics, Inc.2$97
Biohaven Pharmaceuticals, Inc.6$92
Upsher-smith Laboratories LLC5$87
Acadia Pharmaceuticals Inc6$78
Takeda Pharmaceuticals U.S.A., Inc.3$74
Boston Scientific2$65
Amneal Pharmaceuticals LLC4$63
Neurelis, Inc.3$61
Bristol Myers Squibb3$60
Sunovion Pharmaceuticals Inc.4$55
Aucta Pharmaceuticals, Inc.4$54
Catalyst Pharmaceuticals, Inc.1$53
Grifols USA, LLC2$48
Avion Pharmaceuticals3$48
Novo Nordisk1$48
Neurocrine Biosciences, Inc.3$46
Alnylam Pharmaceuticals Inc.2$35
CSL Behring2$33
Ipsen Biopharmaceuticals, Inc2$30
Merz Pharmaceuticals, LLC2$29
Avadel CNS Pharmaceuticals, LLC1$28
Vanda Pharmaceuticals Inc.1$27
GE HealthCare2$25
Tonix Medicines, Inc.1$23
Banner Life Sciences, LLC1$22
Ultragenyx Pharmaceutical Inc.1$21
Jazz Pharmaceuticals Inc.1$19
Aquestive Therapeutics, Inc.1$18
EMD Serono, Inc.1$18
GRT US Holding, Inc.1$18
Sumitomo Pharma America, Inc.1$17
Acorda Therapeutics, Inc1$17
Insightec,inc1$15
Collegium Pharmaceutical, Inc.1$15
Arbor Pharmaceuticals, Inc.1$14
Currax Pharmaceuticals LLC1$13
Supernus Pharmaceuticals, Inc.1$12
Corium, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,132 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$58,423
Medicare patients
341
Services billed
1,142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Emgality PenGalcanezumab-Gnlm153$104,464
Nurtec OdtRimegepant Sulfate63$102,202
UbrelvyUbrogepant52$69,245
Aimovig AutoinjectorErenumab-Aooe47$43,082
QuliptaAtogepant29$30,459
LamictalLamotrigine15$29,619
Topiramate ErTopiramate22$28,137
HorizantGabapentin Enacarbil17$27,850
Ajovy AutoinjectorFremanezumab-Vfrm25$25,449
Glatiramer Acetate13$20,258
Carbamazepine ErCarbamazepine66$15,158
Memantine Hcl213$8,893
Fentanyl21$8,456
Gabapentin438$7,710
Rivastigmine40$6,721

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$340$102,20263 claims
AbbVieUbrelvy, Qulipta$2,878$99,70481 claims
Arbor Pharmaceuticals, Inc.Horizant$14$27,85017 claims
Collegium Pharmaceutical, Inc.Xtampza Er$15$4,04411 claims
Amneal Pharmaceuticals LLCMycophenolate Mofetil$63$2,11028 claims
Upsher-smith Laboratories LLCTopiramate$87$1,696123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →